Healthtech Startups

Allos uses causal AI modeling to optimize pharmaceutical drug formulation and reformulation, mapping chemistry, process variables, and performance data to reduce failed experiments and shorten timelines. It serves innovator and generic drug companies, coordinating CROs and CDMOs to take a molecule from modeling through manufacturing.

2 investors

Allyx Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve and protect synapses in people with neurodegenerative diseases. Its lead compound, ALX-001, is a first-in-class oral therapy acting at mGluR5, currently in Phase 1b clinical development for Alzheimer's disease.

2 investors

ALM Ortho designs and manufactures patient-matched orthopedic implants engineered from CT scan data for complex reconstructions, revision surgeries, tumor resections, and irregular bone defects, working directly with surgeons. It uses electron beam melting to produce porous titanium lattice implants intended for bone ingrowth, delivered through an end-to-end service model from diagnostic scan to operating room.

2 investors

Alpha Tau Medical develops Alpha DaRT, a technology platform for cancer treatment using targeted alpha radiation therapy across multiple cancer types including skin, pancreatic, brain, lung, and prostate cancers at various clinical stages.

2 investors

AlphaNavi Pharma is a pharmaceutical company developing new drugs (Nav channel inhibitors) for patients suffering from chronic pain and neurological disorders. It conducts in-house research and development in collaboration with academia, companies, and investors in Japan and abroad.

2 investors

AlphaRose develops genetic technologies and treatments for children with rare genetic diseases, aiming to make and commercialize such medicines at scale. It targets patients underserved by the current healthcare model for rare genetic conditions.

2 investors

Alpheus is a clinical-stage biotechnology company developing Porphyrin Metabolite Activation (PoMA™), a drug-led oncology approach designed to treat glioblastoma using proprietary low-intensity ultrasound to activate tumor-localized porphyrin metabolites. The company's lead program is in a randomized Phase 2b trial for newly diagnosed glioblastoma.

2 investors

Altasciences operates a drug development platform that integrates nonclinical research, bioanalysis, manufacturing, and Phase I/II clinical execution to compress early-stage drug development timelines from industry standards of 27–51 months to as little as 18 months. The company serves biotech sponsors developing small molecules, monoclonal antibodies, and emerging modalities through parallel workstreams across all development phases.

2 investors

Alteon Health is a physician-owned and physician-led acute care medical group that partners with hospitals and health systems to provide hospitalist medicine, post-acute care, and clinical staffing. Serving patients across 17 US states, it employs physicians and advanced practice providers (APPs) and supports them with data, administrative services, and professional development.

2 investors

Altro provides a platform for wellness businesses to offer clinical services like GLP-1 therapy, hormone therapy, peptides, and lab testing under their own brand, handling compliance, clinical oversight, and pharmacy operations. The service targets independent wellness practitioners including health coaches, medspas, fitness studios, and chiropractors seeking to expand their service offerings and revenue.

2 investors

Alvie offers a health coaching programme called Alvie 360 that combines clinical expertise, coach check-ins, and data analytics to help patients prepare for and recover from medical treatment. It builds individual physical and psychological health profiles to identify and manage risks, serving patients and healthcare partners such as hospitals and clinics.

2 investors

Ambros Therapeutics is a therapeutics company.

2 investors

Amby is an AI coaching app that delivers personalized training plans via text messages, integrating data from Strava, Garmin, and Apple Health to provide proactive check-ins and coaching for endurance athletes. The service focuses on recovery monitoring, training load management, and athlete guidance without requiring a dedicated app interface or new hardware.

2 investors

AMCG develops an AI-powered cardiac diagnostic imaging platform for early diagnosis. The company provides medical device manufacturing and diagnostic solutions using artificial intelligence and big data analytics.

2 investors

Amedes Group organizes continuing education events, webinars, and training seminars for physicians and medical practice teams across Germany, with content delivered by internal medical experts.

2 investors

Amera Health Solutions provides a data integration platform that connects fragmented claims processing systems for health plans. The platform ingests claims from multiple sources and converts them into standardized data, enabling automation and supporting modern benefit designs like direct primary care and reference-based pricing.

2 investors

American Vision Partners is a management organization supporting a network of ophthalmology and eye care practices, including Barnet Dulaney Perkins Eye Center, Southwest Eye Institute, and Retinal Consultants of Arizona. This page presents its National Medical Executive Committee of physicians and optometrists overseeing clinical care across affiliated eye centers in the U.S. Southwest.

2 investors

Amferia develops antimicrobial hydrogel wound dressings that kill bacteria including antibiotic-resistant strains using peptides bonded to hydrogel, for human and veterinary wound care applications. The company's patented technology creates a new class of medical device approved by the FDA for advanced wound management.

2 investors

Amino Collective is an early-stage venture capital firm that invests in health and biotechnology companies at the pre-seed and seed stages. The firm operates with a concentrated investment approach, typically backing a small number of companies annually.

2 investors

Amissa Health quantifies symptoms through wearable data and biometric collection to improve clinical care and research, with a focus on early detection of Alzheimer's and digital biomarkers for perimenopause in women. The company serves healthcare institutions, researchers, and patients seeking personalized treatment guidance.

2 investors

Amnova Biotech develops injectable therapies derived from amniotic biomaterials to promote heart regeneration following ischemic injury. The company targets cardiac regenerative medicine and is advancing its lead therapies from preclinical validation toward clinical application.

2 investors

Amorphous transforms unstructured hospital data into standardized, queryable formats using AI, enabling hospitals to derive operational, financial, and clinical insights for decision-making. The platform serves hospital operations and finance teams by automating data analysis tasks that typically require manual weeks of work.

2 investors

Amparo develops custom-fit prosthetic sockets for lower limb amputees, featuring a remoldable design that adapts to changes in the patient's residual limb. The company serves orthopaedic and prosthetic specialists across 30+ countries, enabling faster and more comfortable prosthetic fitting for post-amputation patients.

2 investors

AMPAworks builds supply chain and inventory management technology to help healthcare organizations improve operational efficiency and reduce costs. Its team of doctors, nurses, and engineers focuses on giving frontline workers the tools and supplies needed to care for patients.

2 investors